Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome

Antihistamine is standard chronic spontaneous urticaria (CSU) therapy. Weight gain is a side effect of concern as prolonged high dose therapy is common. We investigated the effects of 12-weeks loratadine therapy on weight, appetite and parameters of metabolic syndrome (MetS). A cohort study was pe...

Full description

Bibliographic Details
Main Authors: Heah, Swee Kuan, Adawiyah Jamil, Mohan Arumugam, Tang Min Moon, Norlaila Mustafa
Format: Article
Language:English
Published: Penerbit Universiti Kebangsaan Malaysia 2022
Online Access:http://journalarticle.ukm.my/21146/
http://journalarticle.ukm.my/21146/1/50854-189413-1-PB.pdf
_version_ 1848815281721311232
author Heah, Swee Kuan
Adawiyah Jamil,
Mohan Arumugam,
Tang Min Moon,
Norlaila Mustafa,
author_facet Heah, Swee Kuan
Adawiyah Jamil,
Mohan Arumugam,
Tang Min Moon,
Norlaila Mustafa,
author_sort Heah, Swee Kuan
building UKM Institutional Repository
collection Online Access
description Antihistamine is standard chronic spontaneous urticaria (CSU) therapy. Weight gain is a side effect of concern as prolonged high dose therapy is common. We investigated the effects of 12-weeks loratadine therapy on weight, appetite and parameters of metabolic syndrome (MetS). A cohort study was performed involving CSU patients aged ≥18 years. Patients with diseases or on drugs affecting weight or appetite were excluded. CSU was treated according to standard management. Weight, height, waist circumference (WC), body mass index (BMI) and blood pressure (BP), Urticaria Activity Score 7 (UAS7), Dermatology Life Quality Index (DLQI), hunger and satiety questionnaire, fasting blood sugar (FBS) and fasting lipid profile (FLP) were obtained at baseline, week 6 and week 12. Loratadine cumulative dose were determined. Thirteen (33.33 %) males and 26 (66.67 %) females aged 33.00 (12.00) years participated. Median weight was 62.55 (18.30) kg, BMI 24.60 (6.80) kg/m2, 13(33.33%) patients had normal weight, 12 (30.77%) overweight, 11 (28.21%) obese and 3 (7.69%) underweight. Significant weight gain was observed at week 6, 67.56 ± 16.14 kg vs 68.16 ± 16.95 kg, p < 0.05 and 67.56 ± 16.14 kg vs 64.73 ± 14.60 kg, p = 0.04 at week 12. Changes in BMI, WC, BP, FBS and FLP were insignificant. Three patients developed MetS. Hunger and satiety scores were unaffected. Loratadine induced weight gain despite no effects on appetite. Weight should be monitored in patients on long term loratadine therapy.
first_indexed 2025-11-15T00:47:29Z
format Article
id oai:generic.eprints.org:21146
institution Universiti Kebangasaan Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T00:47:29Z
publishDate 2022
publisher Penerbit Universiti Kebangsaan Malaysia
recordtype eprints
repository_type Digital Repository
spelling oai:generic.eprints.org:211462023-02-15T07:13:43Z http://journalarticle.ukm.my/21146/ Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome Heah, Swee Kuan Adawiyah Jamil, Mohan Arumugam, Tang Min Moon, Norlaila Mustafa, Antihistamine is standard chronic spontaneous urticaria (CSU) therapy. Weight gain is a side effect of concern as prolonged high dose therapy is common. We investigated the effects of 12-weeks loratadine therapy on weight, appetite and parameters of metabolic syndrome (MetS). A cohort study was performed involving CSU patients aged ≥18 years. Patients with diseases or on drugs affecting weight or appetite were excluded. CSU was treated according to standard management. Weight, height, waist circumference (WC), body mass index (BMI) and blood pressure (BP), Urticaria Activity Score 7 (UAS7), Dermatology Life Quality Index (DLQI), hunger and satiety questionnaire, fasting blood sugar (FBS) and fasting lipid profile (FLP) were obtained at baseline, week 6 and week 12. Loratadine cumulative dose were determined. Thirteen (33.33 %) males and 26 (66.67 %) females aged 33.00 (12.00) years participated. Median weight was 62.55 (18.30) kg, BMI 24.60 (6.80) kg/m2, 13(33.33%) patients had normal weight, 12 (30.77%) overweight, 11 (28.21%) obese and 3 (7.69%) underweight. Significant weight gain was observed at week 6, 67.56 ± 16.14 kg vs 68.16 ± 16.95 kg, p < 0.05 and 67.56 ± 16.14 kg vs 64.73 ± 14.60 kg, p = 0.04 at week 12. Changes in BMI, WC, BP, FBS and FLP were insignificant. Three patients developed MetS. Hunger and satiety scores were unaffected. Loratadine induced weight gain despite no effects on appetite. Weight should be monitored in patients on long term loratadine therapy. Penerbit Universiti Kebangsaan Malaysia 2022-07 Article PeerReviewed application/pdf en http://journalarticle.ukm.my/21146/1/50854-189413-1-PB.pdf Heah, Swee Kuan and Adawiyah Jamil, and Mohan Arumugam, and Tang Min Moon, and Norlaila Mustafa, (2022) Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome. Jurnal Sains Kesihatan Malaysia, 20 (2). pp. 139-149. ISSN 1675-8161 https://ejournals.ukm.my/jskm/issue/view/1403
spellingShingle Heah, Swee Kuan
Adawiyah Jamil,
Mohan Arumugam,
Tang Min Moon,
Norlaila Mustafa,
Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
title Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
title_full Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
title_fullStr Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
title_full_unstemmed Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
title_short Chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
title_sort chronic spontaneous urticaria in adult patients : evaluating the effect of loratadine on weight and metabolic syndrome
url http://journalarticle.ukm.my/21146/
http://journalarticle.ukm.my/21146/
http://journalarticle.ukm.my/21146/1/50854-189413-1-PB.pdf